Monday, 16 November 2026
Rīga TV

World and Latvian news in one place

HealthPublished: 16 November 2026 at 17:04

Vitamin B12 corrects developmental defects in worms with a Verheij syndrome mutation

Researchers found that vitamin B12 reverses developmental problems in worms carrying a mutation linked to Verheij syndrome, a rare genetic disorder. Whether it helps people has not yet been established.

Foto: ScienceDaily Veselība

A research team working with tiny roundworms has found that vitamin B12 can correct developmental problems in animals carrying a genetic mutation associated with Verheij syndrome. The rare human condition causes developmental delays, impaired growth and short stature. The finding could help scientists better understand, and possibly one day treat, rare genetic disorders, though any therapy remains distant.

What RNA splicing is

The study centers on a cellular process called RNA splicing. It prepares the genetic instructions cells use to build proteins: unneeded sections of messenger RNA are removed and the remaining parts are joined in the correct order. When splicing goes wrong, essential cell functions can be disrupted, contributing to serious developmental disorders. Mutations in genes responsible for splicing can cause conditions such as Verheij syndrome.

Experiments in worms

The work used C. elegans, a roundworm commonly employed in biological research. The scientists were originally looking for unknown genes that influence lifespan when they began studying a mutation in a gene involved in RNA splicing. The same gene is linked to Verheij syndrome in humans. Worms with the mutation grew considerably more slowly and stayed smaller than normal.

Genetic screens and metabolic analysis showed that the mutation disrupted specific metabolic pathways that depend on vitamin B12 and are needed for healthy growth. When the worms were given extra B12, the metabolic processes returned to normal and the developmental abnormalities were corrected.

Relevance to people

The team examined publicly available datasets from human cells and, together with Hormos Dafsari, a neuropediatrician at the University Hospital Cologne, collected blood samples from patients diagnosed with Verheij syndrome. They found signs of similar metabolic changes, suggesting the B12-related pathways may also play a role in the human disorder.

It has not yet been established whether B12 supplementation can improve symptoms in people, and further studies are needed. The researchers add that metabolic disruption may contribute to diseases caused by faulty RNA splicing more than previously recognized.

First author Jonathan Kölschbach said the team was surprised that a change in a basic RNA-processing step had such a targeted effect on B12-dependent metabolism. Adam Antebi, Director at the Max Planck Institute for Biology of Ageing and lead author, said basic research on model organisms can offer new insights into human disease.

Comments

0/1500

Comments are automatically moderated. No hate, threats, personal data or spam.

Loading comments…

More in this category